nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—ALB—atherosclerosis	0.24	1	CbGaD
Cephalexin—SLC22A5—Niacin—atherosclerosis	0.146	0.257	CbGbCtD
Cephalexin—SLC22A8—Pravastatin—atherosclerosis	0.0922	0.162	CbGbCtD
Cephalexin—SLC22A6—Pravastatin—atherosclerosis	0.0642	0.113	CbGbCtD
Cephalexin—ALB—Rosuvastatin—atherosclerosis	0.0601	0.106	CbGbCtD
Cephalexin—CYP2D6—Niacin—atherosclerosis	0.0349	0.0614	CbGbCtD
Cephalexin—CYP2D6—Simvastatin—atherosclerosis	0.0276	0.0485	CbGbCtD
Cephalexin—CYP2D6—Pravastatin—atherosclerosis	0.027	0.0475	CbGbCtD
Cephalexin—CYP2D6—Lovastatin—atherosclerosis	0.027	0.0475	CbGbCtD
Cephalexin—CYP3A4—Rosuvastatin—atherosclerosis	0.0188	0.0332	CbGbCtD
Cephalexin—CYP3A4—Ezetimibe—atherosclerosis	0.0188	0.0332	CbGbCtD
Cephalexin—CYP3A4—Simvastatin—atherosclerosis	0.0175	0.0308	CbGbCtD
Cephalexin—CYP3A4—Lovastatin—atherosclerosis	0.0171	0.0302	CbGbCtD
Cephalexin—CYP3A4—Pravastatin—atherosclerosis	0.0171	0.0302	CbGbCtD
Cephalexin—Gastrointestinal symptom NOS—Niacin—atherosclerosis	0.00239	0.0173	CcSEcCtD
Cephalexin—Jaundice cholestatic—Lovastatin—atherosclerosis	0.00186	0.0135	CcSEcCtD
Cephalexin—Cholestasis—Niacin—atherosclerosis	0.00185	0.0134	CcSEcCtD
Cephalexin—Jaundice cholestatic—Simvastatin—atherosclerosis	0.00174	0.0126	CcSEcCtD
Cephalexin—Phosphatase alkaline increased—Lovastatin—atherosclerosis	0.00163	0.0119	CcSEcCtD
Cephalexin—Phosphatase alkaline increased—Ezetimibe—atherosclerosis	0.0016	0.0116	CcSEcCtD
Cephalexin—Jaundice cholestatic—Niacin—atherosclerosis	0.0016	0.0116	CcSEcCtD
Cephalexin—Jaundice cholestatic—Pravastatin—atherosclerosis	0.00157	0.0114	CcSEcCtD
Cephalexin—Phosphatase alkaline increased—Simvastatin—atherosclerosis	0.00153	0.0111	CcSEcCtD
Cephalexin—Vaginal inflammation—Niacin—atherosclerosis	0.0014	0.0102	CcSEcCtD
Cephalexin—Phosphatase alkaline increased—Pravastatin—atherosclerosis	0.00138	0.01	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Lovastatin—atherosclerosis	0.00136	0.0099	CcSEcCtD
Cephalexin—Hepatic function abnormal—Lovastatin—atherosclerosis	0.00136	0.00985	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Ezetimibe—atherosclerosis	0.00134	0.00971	CcSEcCtD
Cephalexin—Vaginal infection—Niacin—atherosclerosis	0.00132	0.00962	CcSEcCtD
Cephalexin—Haemolytic anaemia—Lovastatin—atherosclerosis	0.00131	0.00954	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Simvastatin—atherosclerosis	0.00128	0.00926	CcSEcCtD
Cephalexin—Hepatic function abnormal—Simvastatin—atherosclerosis	0.00127	0.00922	CcSEcCtD
Cephalexin—Cefazolin—PON1—atherosclerosis	0.00126	0.381	CrCbGaD
Cephalexin—Breast disorder—Rosuvastatin—atherosclerosis	0.00126	0.00918	CcSEcCtD
Cephalexin—Haemolytic anaemia—Simvastatin—atherosclerosis	0.00123	0.00892	CcSEcCtD
Cephalexin—Arthritis—Lovastatin—atherosclerosis	0.00122	0.00886	CcSEcCtD
Cephalexin—Arthritis—Ezetimibe—atherosclerosis	0.0012	0.00869	CcSEcCtD
Cephalexin—Hepatic function abnormal—Niacin—atherosclerosis	0.00117	0.00846	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Pravastatin—atherosclerosis	0.00115	0.00837	CcSEcCtD
Cephalexin—Hepatic function abnormal—Pravastatin—atherosclerosis	0.00115	0.00833	CcSEcCtD
Cephalexin—Arthritis—Simvastatin—atherosclerosis	0.00114	0.00829	CcSEcCtD
Cephalexin—Haemolytic anaemia—Pravastatin—atherosclerosis	0.00111	0.00807	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.00107	0.00775	CcSEcCtD
Cephalexin—Breast disorder—Ezetimibe—atherosclerosis	0.00105	0.00763	CcSEcCtD
Cephalexin—Arthritis—Niacin—atherosclerosis	0.00105	0.00761	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00105	0.0076	CcSEcCtD
Cephalexin—Arthritis—Pravastatin—atherosclerosis	0.00103	0.00749	CcSEcCtD
Cephalexin—Gastritis—Ezetimibe—atherosclerosis	0.00103	0.00747	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00103	0.00745	CcSEcCtD
Cephalexin—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00102	0.0074	CcSEcCtD
Cephalexin—Eosinophilia—Lovastatin—atherosclerosis	0.00101	0.00737	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.000999	0.00725	CcSEcCtD
Cephalexin—Eosinophilia—Ezetimibe—atherosclerosis	0.000995	0.00723	CcSEcCtD
Cephalexin—Gastritis—Simvastatin—atherosclerosis	0.000982	0.00713	CcSEcCtD
Cephalexin—Hepatitis—Rosuvastatin—atherosclerosis	0.000968	0.00703	CcSEcCtD
Cephalexin—Eosinophilia—Simvastatin—atherosclerosis	0.000949	0.00689	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000906	0.00658	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.000903	0.00656	CcSEcCtD
Cephalexin—Infestation NOS—Ezetimibe—atherosclerosis	0.000896	0.00651	CcSEcCtD
Cephalexin—Infestation—Ezetimibe—atherosclerosis	0.000896	0.00651	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.000884	0.00642	CcSEcCtD
Cephalexin—Eosinophilia—Pravastatin—atherosclerosis	0.000858	0.00623	CcSEcCtD
Cephalexin—Mental disorder—Rosuvastatin—atherosclerosis	0.000848	0.00616	CcSEcCtD
Cephalexin—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000848	0.00616	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000847	0.00615	CcSEcCtD
Cephalexin—Hepatitis—Lovastatin—atherosclerosis	0.00082	0.00596	CcSEcCtD
Cephalexin—Hepatitis—Ezetimibe—atherosclerosis	0.000805	0.00584	CcSEcCtD
Cephalexin—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000791	0.00574	CcSEcCtD
Cephalexin—Erythema multiforme—Lovastatin—atherosclerosis	0.000776	0.00563	CcSEcCtD
Cephalexin—Angioedema—Rosuvastatin—atherosclerosis	0.00077	0.00559	CcSEcCtD
Cephalexin—Hepatitis—Simvastatin—atherosclerosis	0.000767	0.00557	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000766	0.00556	CcSEcCtD
Cephalexin—Erythema multiforme—Ezetimibe—atherosclerosis	0.000761	0.00552	CcSEcCtD
Cephalexin—Immune system disorder—Ezetimibe—atherosclerosis	0.000727	0.00528	CcSEcCtD
Cephalexin—Erythema multiforme—Simvastatin—atherosclerosis	0.000725	0.00527	CcSEcCtD
Cephalexin—Arthralgia—Rosuvastatin—atherosclerosis	0.000717	0.00521	CcSEcCtD
Cephalexin—Haemoglobin—Niacin—atherosclerosis	0.000708	0.00514	CcSEcCtD
Cephalexin—Mental disorder—Ezetimibe—atherosclerosis	0.000705	0.00512	CcSEcCtD
Cephalexin—Haemorrhage—Niacin—atherosclerosis	0.000704	0.00512	CcSEcCtD
Cephalexin—Hepatitis—Niacin—atherosclerosis	0.000704	0.00512	CcSEcCtD
Cephalexin—Hepatitis—Pravastatin—atherosclerosis	0.000694	0.00504	CcSEcCtD
Cephalexin—Confusional state—Rosuvastatin—atherosclerosis	0.000693	0.00504	CcSEcCtD
Cephalexin—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000674	0.0049	CcSEcCtD
Cephalexin—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000673	0.00489	CcSEcCtD
Cephalexin—Mental disorder—Simvastatin—atherosclerosis	0.000672	0.00488	CcSEcCtD
Cephalexin—Erythema multiforme—Pravastatin—atherosclerosis	0.000656	0.00476	CcSEcCtD
Cephalexin—Angioedema—Lovastatin—atherosclerosis	0.000652	0.00474	CcSEcCtD
Cephalexin—Angioedema—Ezetimibe—atherosclerosis	0.00064	0.00465	CcSEcCtD
Cephalexin—Leukopenia—Lovastatin—atherosclerosis	0.000639	0.00464	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000627	0.00455	CcSEcCtD
Cephalexin—Angioedema—Simvastatin—atherosclerosis	0.00061	0.00443	CcSEcCtD
Cephalexin—Arthralgia—Lovastatin—atherosclerosis	0.000608	0.00441	CcSEcCtD
Cephalexin—Dyspepsia—Rosuvastatin—atherosclerosis	0.000605	0.0044	CcSEcCtD
Cephalexin—Leukopenia—Simvastatin—atherosclerosis	0.000598	0.00434	CcSEcCtD
Cephalexin—Arthralgia—Ezetimibe—atherosclerosis	0.000596	0.00433	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000592	0.0043	CcSEcCtD
Cephalexin—Confusional state—Lovastatin—atherosclerosis	0.000588	0.00427	CcSEcCtD
Cephalexin—Anaphylactic shock—Lovastatin—atherosclerosis	0.000583	0.00423	CcSEcCtD
Cephalexin—Confusional state—Ezetimibe—atherosclerosis	0.000576	0.00419	CcSEcCtD
Cephalexin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000572	0.00415	CcSEcCtD
Cephalexin—Thrombocytopenia—Lovastatin—atherosclerosis	0.000571	0.00414	CcSEcCtD
Cephalexin—Arthralgia—Simvastatin—atherosclerosis	0.000569	0.00413	CcSEcCtD
Cephalexin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000567	0.00412	CcSEcCtD
Cephalexin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000562	0.00408	CcSEcCtD
Cephalexin—Nervous system disorder—Ezetimibe—atherosclerosis	0.000561	0.00407	CcSEcCtD
Cephalexin—Angioedema—Niacin—atherosclerosis	0.00056	0.00407	CcSEcCtD
Cephalexin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00056	0.00406	CcSEcCtD
Cephalexin—Skin disorder—Ezetimibe—atherosclerosis	0.000555	0.00403	CcSEcCtD
Cephalexin—Angioedema—Pravastatin—atherosclerosis	0.000552	0.00401	CcSEcCtD
Cephalexin—Confusional state—Simvastatin—atherosclerosis	0.00055	0.00399	CcSEcCtD
Cephalexin—Leukopenia—Niacin—atherosclerosis	0.000549	0.00399	CcSEcCtD
Cephalexin—Urticaria—Rosuvastatin—atherosclerosis	0.000546	0.00397	CcSEcCtD
Cephalexin—Anaphylactic shock—Simvastatin—atherosclerosis	0.000545	0.00396	CcSEcCtD
Cephalexin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000544	0.00395	CcSEcCtD
Cephalexin—Leukopenia—Pravastatin—atherosclerosis	0.000541	0.00393	CcSEcCtD
Cephalexin—Thrombocytopenia—Simvastatin—atherosclerosis	0.000534	0.00388	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000531	0.00386	CcSEcCtD
Cephalexin—Arthralgia—Niacin—atherosclerosis	0.000522	0.00379	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000521	0.00378	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000519	0.00377	CcSEcCtD
Cephalexin—Cefdinir—MPO—atherosclerosis	0.000517	0.156	CrCbGaD
Cephalexin—Arthralgia—Pravastatin—atherosclerosis	0.000514	0.00373	CcSEcCtD
Cephalexin—Dyspepsia—Lovastatin—atherosclerosis	0.000513	0.00373	CcSEcCtD
Cephalexin—Cefaclor—MPO—atherosclerosis	0.000513	0.154	CrCbGaD
Cephalexin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000507	0.00368	CcSEcCtD
Cephalexin—Dyspepsia—Ezetimibe—atherosclerosis	0.000503	0.00365	CcSEcCtD
Cephalexin—Fatigue—Lovastatin—atherosclerosis	0.000502	0.00365	CcSEcCtD
Cephalexin—Anaphylactic shock—Niacin—atherosclerosis	0.000501	0.00363	CcSEcCtD
Cephalexin—Confusional state—Pravastatin—atherosclerosis	0.000497	0.00361	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000497	0.00361	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000493	0.00358	CcSEcCtD
Cephalexin—Asthenia—Rosuvastatin—atherosclerosis	0.000493	0.00358	CcSEcCtD
Cephalexin—Anaphylactic shock—Pravastatin—atherosclerosis	0.000493	0.00358	CcSEcCtD
Cephalexin—Fatigue—Ezetimibe—atherosclerosis	0.000493	0.00358	CcSEcCtD
Cephalexin—Pruritus—Rosuvastatin—atherosclerosis	0.000487	0.00353	CcSEcCtD
Cephalexin—Skin disorder—Niacin—atherosclerosis	0.000486	0.00353	CcSEcCtD
Cephalexin—Thrombocytopenia—Pravastatin—atherosclerosis	0.000483	0.0035	CcSEcCtD
Cephalexin—Feeling abnormal—Lovastatin—atherosclerosis	0.00048	0.00349	CcSEcCtD
Cephalexin—Dyspepsia—Simvastatin—atherosclerosis	0.00048	0.00348	CcSEcCtD
Cephalexin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000477	0.00346	CcSEcCtD
Cephalexin—Feeling abnormal—Ezetimibe—atherosclerosis	0.000471	0.00342	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000471	0.00342	CcSEcCtD
Cephalexin—Diarrhoea—Rosuvastatin—atherosclerosis	0.00047	0.00342	CcSEcCtD
Cephalexin—Fatigue—Simvastatin—atherosclerosis	0.00047	0.00341	CcSEcCtD
Cephalexin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000467	0.00339	CcSEcCtD
Cephalexin—Urticaria—Lovastatin—atherosclerosis	0.000463	0.00336	CcSEcCtD
Cephalexin—Body temperature increased—Lovastatin—atherosclerosis	0.000461	0.00335	CcSEcCtD
Cephalexin—Abdominal pain—Lovastatin—atherosclerosis	0.000461	0.00335	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000456	0.00331	CcSEcCtD
Cephalexin—Dizziness—Rosuvastatin—atherosclerosis	0.000455	0.0033	CcSEcCtD
Cephalexin—Urticaria—Ezetimibe—atherosclerosis	0.000454	0.0033	CcSEcCtD
Cephalexin—Body temperature increased—Ezetimibe—atherosclerosis	0.000452	0.00328	CcSEcCtD
Cephalexin—Abdominal pain—Ezetimibe—atherosclerosis	0.000452	0.00328	CcSEcCtD
Cephalexin—Feeling abnormal—Simvastatin—atherosclerosis	0.000449	0.00326	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000449	0.00326	CcSEcCtD
Cephalexin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000446	0.00324	CcSEcCtD
Cephalexin—Dyspepsia—Niacin—atherosclerosis	0.000441	0.0032	CcSEcCtD
Cephalexin—Dyspepsia—Pravastatin—atherosclerosis	0.000434	0.00315	CcSEcCtD
Cephalexin—Rash—Rosuvastatin—atherosclerosis	0.000434	0.00315	CcSEcCtD
Cephalexin—Dermatitis—Rosuvastatin—atherosclerosis	0.000433	0.00315	CcSEcCtD
Cephalexin—Urticaria—Simvastatin—atherosclerosis	0.000433	0.00314	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Niacin—atherosclerosis	0.000432	0.00314	CcSEcCtD
Cephalexin—Abdominal pain—Simvastatin—atherosclerosis	0.000431	0.00313	CcSEcCtD
Cephalexin—Body temperature increased—Simvastatin—atherosclerosis	0.000431	0.00313	CcSEcCtD
Cephalexin—Headache—Rosuvastatin—atherosclerosis	0.000431	0.00313	CcSEcCtD
Cephalexin—Hypersensitivity—Lovastatin—atherosclerosis	0.000429	0.00312	CcSEcCtD
Cephalexin—Fatigue—Pravastatin—atherosclerosis	0.000425	0.00309	CcSEcCtD
Cephalexin—Hypersensitivity—Ezetimibe—atherosclerosis	0.000421	0.00306	CcSEcCtD
Cephalexin—Asthenia—Lovastatin—atherosclerosis	0.000418	0.00304	CcSEcCtD
Cephalexin—Pruritus—Lovastatin—atherosclerosis	0.000412	0.00299	CcSEcCtD
Cephalexin—Asthenia—Ezetimibe—atherosclerosis	0.00041	0.00298	CcSEcCtD
Cephalexin—Gastrointestinal pain—Niacin—atherosclerosis	0.000409	0.00297	CcSEcCtD
Cephalexin—Nausea—Rosuvastatin—atherosclerosis	0.000408	0.00297	CcSEcCtD
Cephalexin—Feeling abnormal—Pravastatin—atherosclerosis	0.000406	0.00295	CcSEcCtD
Cephalexin—Pruritus—Ezetimibe—atherosclerosis	0.000404	0.00294	CcSEcCtD
Cephalexin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000403	0.00293	CcSEcCtD
Cephalexin—Hypersensitivity—Simvastatin—atherosclerosis	0.000402	0.00292	CcSEcCtD
Cephalexin—Diarrhoea—Lovastatin—atherosclerosis	0.000399	0.0029	CcSEcCtD
Cephalexin—Urticaria—Niacin—atherosclerosis	0.000398	0.00289	CcSEcCtD
Cephalexin—Abdominal pain—Niacin—atherosclerosis	0.000396	0.00287	CcSEcCtD
Cephalexin—Body temperature increased—Niacin—atherosclerosis	0.000396	0.00287	CcSEcCtD
Cephalexin—Urticaria—Pravastatin—atherosclerosis	0.000391	0.00284	CcSEcCtD
Cephalexin—Asthenia—Simvastatin—atherosclerosis	0.000391	0.00284	CcSEcCtD
Cephalexin—Diarrhoea—Ezetimibe—atherosclerosis	0.000391	0.00284	CcSEcCtD
Cephalexin—Body temperature increased—Pravastatin—atherosclerosis	0.00039	0.00283	CcSEcCtD
Cephalexin—Abdominal pain—Pravastatin—atherosclerosis	0.00039	0.00283	CcSEcCtD
Cephalexin—Pruritus—Simvastatin—atherosclerosis	0.000386	0.0028	CcSEcCtD
Cephalexin—Dizziness—Lovastatin—atherosclerosis	0.000385	0.0028	CcSEcCtD
Cephalexin—Dizziness—Ezetimibe—atherosclerosis	0.000378	0.00274	CcSEcCtD
Cephalexin—Diarrhoea—Simvastatin—atherosclerosis	0.000373	0.00271	CcSEcCtD
Cephalexin—Vomiting—Lovastatin—atherosclerosis	0.000371	0.00269	CcSEcCtD
Cephalexin—Hypersensitivity—Niacin—atherosclerosis	0.000369	0.00268	CcSEcCtD
Cephalexin—Rash—Lovastatin—atherosclerosis	0.000367	0.00267	CcSEcCtD
Cephalexin—Dermatitis—Lovastatin—atherosclerosis	0.000367	0.00267	CcSEcCtD
Cephalexin—Headache—Lovastatin—atherosclerosis	0.000365	0.00265	CcSEcCtD
Cephalexin—Vomiting—Ezetimibe—atherosclerosis	0.000363	0.00264	CcSEcCtD
Cephalexin—Hypersensitivity—Pravastatin—atherosclerosis	0.000363	0.00264	CcSEcCtD
Cephalexin—Dizziness—Simvastatin—atherosclerosis	0.00036	0.00262	CcSEcCtD
Cephalexin—Rash—Ezetimibe—atherosclerosis	0.00036	0.00262	CcSEcCtD
Cephalexin—Dermatitis—Ezetimibe—atherosclerosis	0.00036	0.00261	CcSEcCtD
Cephalexin—Asthenia—Niacin—atherosclerosis	0.000359	0.00261	CcSEcCtD
Cephalexin—Headache—Ezetimibe—atherosclerosis	0.000358	0.0026	CcSEcCtD
Cephalexin—Pruritus—Niacin—atherosclerosis	0.000354	0.00257	CcSEcCtD
Cephalexin—Asthenia—Pravastatin—atherosclerosis	0.000354	0.00257	CcSEcCtD
Cephalexin—Pruritus—Pravastatin—atherosclerosis	0.000349	0.00253	CcSEcCtD
Cephalexin—Vomiting—Simvastatin—atherosclerosis	0.000347	0.00252	CcSEcCtD
Cephalexin—Nausea—Lovastatin—atherosclerosis	0.000346	0.00251	CcSEcCtD
Cephalexin—Rash—Simvastatin—atherosclerosis	0.000344	0.0025	CcSEcCtD
Cephalexin—Dermatitis—Simvastatin—atherosclerosis	0.000343	0.00249	CcSEcCtD
Cephalexin—Diarrhoea—Niacin—atherosclerosis	0.000342	0.00249	CcSEcCtD
Cephalexin—Headache—Simvastatin—atherosclerosis	0.000341	0.00248	CcSEcCtD
Cephalexin—Nausea—Ezetimibe—atherosclerosis	0.00034	0.00247	CcSEcCtD
Cephalexin—Diarrhoea—Pravastatin—atherosclerosis	0.000337	0.00245	CcSEcCtD
Cephalexin—Cefpiramide—ALB—atherosclerosis	0.000334	0.1	CrCbGaD
Cephalexin—Dizziness—Niacin—atherosclerosis	0.000331	0.0024	CcSEcCtD
Cephalexin—Dizziness—Pravastatin—atherosclerosis	0.000326	0.00237	CcSEcCtD
Cephalexin—Nausea—Simvastatin—atherosclerosis	0.000324	0.00235	CcSEcCtD
Cephalexin—Vomiting—Niacin—atherosclerosis	0.000318	0.00231	CcSEcCtD
Cephalexin—Rash—Niacin—atherosclerosis	0.000316	0.00229	CcSEcCtD
Cephalexin—Dermatitis—Niacin—atherosclerosis	0.000315	0.00229	CcSEcCtD
Cephalexin—Headache—Niacin—atherosclerosis	0.000314	0.00228	CcSEcCtD
Cephalexin—Vomiting—Pravastatin—atherosclerosis	0.000313	0.00228	CcSEcCtD
Cephalexin—Rash—Pravastatin—atherosclerosis	0.000311	0.00226	CcSEcCtD
Cephalexin—Dermatitis—Pravastatin—atherosclerosis	0.00031	0.00225	CcSEcCtD
Cephalexin—Headache—Pravastatin—atherosclerosis	0.000309	0.00224	CcSEcCtD
Cephalexin—Nausea—Niacin—atherosclerosis	0.000297	0.00216	CcSEcCtD
Cephalexin—Nausea—Pravastatin—atherosclerosis	0.000293	0.00213	CcSEcCtD
Cephalexin—Cefonicid—ALB—atherosclerosis	0.000291	0.0875	CrCbGaD
Cephalexin—Ampicillin—ALB—atherosclerosis	0.000146	0.0438	CrCbGaD
Cephalexin—Cefazolin—ALB—atherosclerosis	0.000141	0.0424	CrCbGaD
Cephalexin—Cefalotin—ALB—atherosclerosis	0.000117	0.0352	CrCbGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	3.94e-05	0.000775	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—CLU—atherosclerosis	3.91e-05	0.00077	CbGpPWpGaD
Cephalexin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	3.86e-05	0.00076	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—NFKB1—atherosclerosis	3.83e-05	0.000754	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.8e-05	0.000748	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—GSTM1—atherosclerosis	3.78e-05	0.000744	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.76e-05	0.00074	CbGpPWpGaD
Cephalexin—ALB—Platelet degranulation—VEGFA—atherosclerosis	3.75e-05	0.000738	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—TNF—atherosclerosis	3.75e-05	0.000738	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—PLG—atherosclerosis	3.74e-05	0.000736	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	3.73e-05	0.000735	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	3.73e-05	0.000735	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	3.73e-05	0.000735	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	3.73e-05	0.000735	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—GSTM1—atherosclerosis	3.73e-05	0.000734	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—IL6—atherosclerosis	3.72e-05	0.000732	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.7e-05	0.000727	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	3.69e-05	0.000726	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—THBD—atherosclerosis	3.68e-05	0.000724	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—TRPV1—atherosclerosis	3.64e-05	0.000717	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—PRKCG—atherosclerosis	3.58e-05	0.000704	CbGpPWpGaD
Cephalexin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—atherosclerosis	3.58e-05	0.000704	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	3.56e-05	0.000701	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.53e-05	0.000694	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—ABCG5—atherosclerosis	3.51e-05	0.00069	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—CD36—atherosclerosis	3.5e-05	0.000688	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SELE—atherosclerosis	3.49e-05	0.000686	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.47e-05	0.000682	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.45e-05	0.00068	CbGpPWpGaD
Cephalexin—ALB—Platelet degranulation—TGFB1—atherosclerosis	3.44e-05	0.000678	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	3.41e-05	0.000672	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.34e-05	0.000658	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—APOB—atherosclerosis	3.31e-05	0.000651	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	3.29e-05	0.000647	CbGpPWpGaD
Cephalexin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—atherosclerosis	3.28e-05	0.000646	CbGpPWpGaD
Cephalexin—ALB—Metabolism—LDLRAP1—atherosclerosis	3.25e-05	0.000639	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—PDGFB—atherosclerosis	3.22e-05	0.000635	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	3.17e-05	0.000625	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.14e-05	0.000617	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—VWF—atherosclerosis	3.11e-05	0.000612	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PLTP—atherosclerosis	3.05e-05	0.000601	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—APOA1—atherosclerosis	3.05e-05	0.0006	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—IL6—atherosclerosis	3.03e-05	0.000596	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—ALB—atherosclerosis	3.01e-05	0.000592	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—TNF—atherosclerosis	2.98e-05	0.000586	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—F7—atherosclerosis	2.97e-05	0.000583	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—F2—atherosclerosis	2.91e-05	0.000572	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	2.83e-05	0.000557	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	2.81e-05	0.000553	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	2.8e-05	0.00055	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.79e-05	0.00055	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.79e-05	0.000549	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—PIK3CG—atherosclerosis	2.78e-05	0.000548	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—ALB—atherosclerosis	2.75e-05	0.000541	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	2.73e-05	0.000537	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—LDLRAP1—atherosclerosis	2.68e-05	0.000528	CbGpPWpGaD
Cephalexin—ALB—Metabolism—LTA4H—atherosclerosis	2.65e-05	0.000521	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ABCG8—atherosclerosis	2.65e-05	0.000521	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PLAT—atherosclerosis	2.64e-05	0.00052	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.62e-05	0.000515	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.61e-05	0.000514	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—CETP—atherosclerosis	2.6e-05	0.000511	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—IGF1—atherosclerosis	2.55e-05	0.000502	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PLTP—atherosclerosis	2.52e-05	0.000496	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—ALB—atherosclerosis	2.48e-05	0.000489	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	2.47e-05	0.000487	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.47e-05	0.000486	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	2.44e-05	0.00048	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—SERPINE1—atherosclerosis	2.42e-05	0.000476	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—IL6—atherosclerosis	2.41e-05	0.000473	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—KNG1—atherosclerosis	2.32e-05	0.000456	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PLAUR—atherosclerosis	2.3e-05	0.000452	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—PLAT—atherosclerosis	2.29e-05	0.00045	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PLG—atherosclerosis	2.25e-05	0.000442	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.2e-05	0.000433	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—LTA4H—atherosclerosis	2.19e-05	0.00043	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ABCG8—atherosclerosis	2.19e-05	0.00043	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SOD1—atherosclerosis	2.15e-05	0.000424	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ABCG1—atherosclerosis	2.09e-05	0.000412	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—ALB—atherosclerosis	2.07e-05	0.000408	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IGF2—atherosclerosis	2.05e-05	0.000403	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—APOB—atherosclerosis	1.99e-05	0.000391	CbGpPWpGaD
Cephalexin—ALB—Metabolism—LCAT—atherosclerosis	1.97e-05	0.000387	CbGpPWpGaD
Cephalexin—ALB—Metabolism—FABP4—atherosclerosis	1.97e-05	0.000387	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—PLG—atherosclerosis	1.95e-05	0.000383	CbGpPWpGaD
Cephalexin—ALB—Metabolism—APOA4—atherosclerosis	1.93e-05	0.00038	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP7A1—atherosclerosis	1.9e-05	0.000373	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PRKCG—atherosclerosis	1.84e-05	0.000363	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.81e-05	0.000356	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—CD36—atherosclerosis	1.8e-05	0.000355	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.8e-05	0.000353	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP27A1—atherosclerosis	1.75e-05	0.000345	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.75e-05	0.000345	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ABCG1—atherosclerosis	1.73e-05	0.00034	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.73e-05	0.00034	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—APOB—atherosclerosis	1.72e-05	0.000338	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.68e-05	0.000331	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	1.66e-05	0.000328	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ALOX15—atherosclerosis	1.66e-05	0.000327	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ALOX5AP—atherosclerosis	1.66e-05	0.000327	CbGpPWpGaD
Cephalexin—ALB—Metabolism—APOA2—atherosclerosis	1.66e-05	0.000327	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PLA2G2A—atherosclerosis	1.66e-05	0.000327	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PDGFB—atherosclerosis	1.66e-05	0.000327	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PLTP—atherosclerosis	1.65e-05	0.000324	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—MMP1—atherosclerosis	1.64e-05	0.000323	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ABCG5—atherosclerosis	1.64e-05	0.000323	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.64e-05	0.000323	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—FABP4—atherosclerosis	1.62e-05	0.00032	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—LCAT—atherosclerosis	1.62e-05	0.00032	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—APOA4—atherosclerosis	1.59e-05	0.000314	CbGpPWpGaD
Cephalexin—ALB—Metabolism—LPA—atherosclerosis	1.59e-05	0.000312	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—CAV1—atherosclerosis	1.58e-05	0.00031	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	1.57e-05	0.00031	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—APOA1—atherosclerosis	1.57e-05	0.000309	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP7A1—atherosclerosis	1.57e-05	0.000308	CbGpPWpGaD
Cephalexin—ALB—Metabolism—BGN—atherosclerosis	1.54e-05	0.000302	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	1.53e-05	0.000301	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.53e-05	0.0003	CbGpPWpGaD
Cephalexin—ALB—Metabolism—APOA5—atherosclerosis	1.52e-05	0.000299	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—F2—atherosclerosis	1.5e-05	0.000295	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—NOS2—atherosclerosis	1.48e-05	0.000292	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.48e-05	0.000291	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PLA2G1B—atherosclerosis	1.46e-05	0.000288	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.45e-05	0.000285	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP27A1—atherosclerosis	1.45e-05	0.000285	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.45e-05	0.000285	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3CG—atherosclerosis	1.43e-05	0.000282	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.43e-05	0.000282	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.43e-05	0.000282	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.43e-05	0.000281	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.43e-05	0.000281	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ALOX5—atherosclerosis	1.41e-05	0.000278	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—APOA2—atherosclerosis	1.37e-05	0.00027	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.37e-05	0.00027	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.37e-05	0.00027	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.37e-05	0.00027	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.36e-05	0.000268	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.36e-05	0.000267	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IGF1—atherosclerosis	1.31e-05	0.000259	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—LPA—atherosclerosis	1.31e-05	0.000258	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.31e-05	0.000257	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—BGN—atherosclerosis	1.27e-05	0.00025	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NAMPT—atherosclerosis	1.27e-05	0.00025	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.26e-05	0.000248	CbGpPWpGaD
Cephalexin—ALB—Metabolism—LIPC—atherosclerosis	1.26e-05	0.000248	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—APOA5—atherosclerosis	1.26e-05	0.000247	CbGpPWpGaD
Cephalexin—ALB—Metabolism—APOC3—atherosclerosis	1.25e-05	0.000246	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SERPINE1—atherosclerosis	1.25e-05	0.000245	CbGpPWpGaD
Cephalexin—ALB—Metabolism—LDLR—atherosclerosis	1.24e-05	0.000245	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CETP—atherosclerosis	1.22e-05	0.000239	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.21e-05	0.000238	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—NOS3—atherosclerosis	1.19e-05	0.000234	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.17e-05	0.00023	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SCARB1—atherosclerosis	1.16e-05	0.000229	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.13e-05	0.000222	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HMGCR—atherosclerosis	1.1e-05	0.000216	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—FABP4—atherosclerosis	1.06e-05	0.000209	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—LCAT—atherosclerosis	1.06e-05	0.000209	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.06e-05	0.000209	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.05e-05	0.000206	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—APOA4—atherosclerosis	1.04e-05	0.000205	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—LIPC—atherosclerosis	1.04e-05	0.000205	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—APOC3—atherosclerosis	1.03e-05	0.000203	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—LDLR—atherosclerosis	1.03e-05	0.000202	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.02e-05	0.000202	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CETP—atherosclerosis	1e-05	0.000198	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.92e-06	0.000195	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ABCA1—atherosclerosis	9.8e-06	0.000193	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SCARB1—atherosclerosis	9.61e-06	0.000189	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP27A1—atherosclerosis	9.47e-06	0.000186	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HMGCR—atherosclerosis	9.08e-06	0.000179	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—APOA2—atherosclerosis	8.98e-06	0.000177	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	8.98e-06	0.000177	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	8.98e-06	0.000177	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ALOX15—atherosclerosis	8.98e-06	0.000177	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ABCG5—atherosclerosis	8.87e-06	0.000174	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—VEGFA—atherosclerosis	8.58e-06	0.000169	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—LPA—atherosclerosis	8.56e-06	0.000168	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HMOX1—atherosclerosis	8.41e-06	0.000165	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—BGN—atherosclerosis	8.29e-06	0.000163	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—APOA5—atherosclerosis	8.21e-06	0.000162	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—MAPK3—atherosclerosis	8.12e-06	0.00016	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ABCA1—atherosclerosis	8.09e-06	0.000159	CbGpPWpGaD
Cephalexin—ALB—Metabolism—APOB—atherosclerosis	8.05e-06	0.000158	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	7.9e-06	0.000156	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—TGFB1—atherosclerosis	7.88e-06	0.000155	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTM1—atherosclerosis	7.83e-06	0.000154	CbGpPWpGaD
Cephalexin—ALB—Metabolism—LPL—atherosclerosis	7.69e-06	0.000151	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ALOX5—atherosclerosis	7.63e-06	0.00015	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GPX1—atherosclerosis	7.5e-06	0.000148	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CD36—atherosclerosis	7.31e-06	0.000144	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HMOX1—atherosclerosis	6.94e-06	0.000137	CbGpPWpGaD
Cephalexin—ALB—Metabolism—MTHFR—atherosclerosis	6.92e-06	0.000136	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NAMPT—atherosclerosis	6.85e-06	0.000135	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—LIPC—atherosclerosis	6.8e-06	0.000134	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PPARA—atherosclerosis	6.79e-06	0.000134	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—APOC3—atherosclerosis	6.76e-06	0.000133	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—LDLR—atherosclerosis	6.72e-06	0.000132	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—APOB—atherosclerosis	6.65e-06	0.000131	CbGpPWpGaD
Cephalexin—ALB—Metabolism—AGT—atherosclerosis	6.58e-06	0.000129	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CETP—atherosclerosis	6.56e-06	0.000129	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTM1—atherosclerosis	6.47e-06	0.000127	CbGpPWpGaD
Cephalexin—ALB—Metabolism—APOE—atherosclerosis	6.45e-06	0.000127	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CAV1—atherosclerosis	6.39e-06	0.000126	CbGpPWpGaD
Cephalexin—ALB—Metabolism—APOA1—atherosclerosis	6.37e-06	0.000125	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—LPL—atherosclerosis	6.35e-06	0.000125	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.29e-06	0.000124	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GPX1—atherosclerosis	6.19e-06	0.000122	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CD36—atherosclerosis	6.03e-06	0.000119	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HMGCR—atherosclerosis	5.94e-06	0.000117	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3CG—atherosclerosis	5.82e-06	0.000114	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—MTHFR—atherosclerosis	5.72e-06	0.000112	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PPARG—atherosclerosis	5.61e-06	0.00011	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PPARA—atherosclerosis	5.61e-06	0.00011	CbGpPWpGaD
Cephalexin—ALB—Metabolism—INS—atherosclerosis	5.51e-06	0.000108	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—AKT1—atherosclerosis	5.48e-06	0.000108	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—AGT—atherosclerosis	5.43e-06	0.000107	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—APOE—atherosclerosis	5.32e-06	0.000105	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.29e-06	0.000104	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CAV1—atherosclerosis	5.27e-06	0.000104	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—APOA1—atherosclerosis	5.26e-06	0.000104	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NOS3—atherosclerosis	4.83e-06	9.5e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3CG—atherosclerosis	4.8e-06	9.45e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PPARG—atherosclerosis	4.64e-06	9.12e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—INS—atherosclerosis	4.55e-06	8.95e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.54e-06	8.93e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PTGS2—atherosclerosis	4.42e-06	8.69e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—APOB—atherosclerosis	4.35e-06	8.55e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.23e-06	8.32e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ALB—atherosclerosis	4.17e-06	8.2e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—LPL—atherosclerosis	4.15e-06	8.17e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GPX1—atherosclerosis	4.05e-06	7.97e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NOS3—atherosclerosis	3.99e-06	7.85e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CD36—atherosclerosis	3.94e-06	7.76e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.74e-06	7.35e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PPARA—atherosclerosis	3.67e-06	7.22e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.65e-06	7.18e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—AGT—atherosclerosis	3.55e-06	6.99e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—APOE—atherosclerosis	3.48e-06	6.85e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CAV1—atherosclerosis	3.45e-06	6.78e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—APOA1—atherosclerosis	3.44e-06	6.77e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.14e-06	6.18e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PPARG—atherosclerosis	3.03e-06	5.96e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—INS—atherosclerosis	2.97e-06	5.85e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ALB—atherosclerosis	2.73e-06	5.36e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NOS3—atherosclerosis	2.61e-06	5.13e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.38e-06	4.69e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—AKT1—atherosclerosis	2.22e-06	4.37e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—AKT1—atherosclerosis	1.83e-06	3.61e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—AKT1—atherosclerosis	1.2e-06	2.36e-05	CbGpPWpGaD
